Spiro tetrahydroquinazolines and dihydrocyclopentapyrimidines as CRF antagonists

摘要

Compounds of the formula (I): and pharmaceutically acceptable salts or prodrugs thereof, wherein X, Y, Z and R¹ are as defined herein. The invention also provides methods for preparing, compositions comprising, and methods for using compounds of formula I.